Broking house, P-Sec recommended hold rating on Thermax.

P-Sec report on Thermax:

Thermax reported a growth of 107% yoy and a bottom line growth of 103% yoy. The results bettered our expectations with a big margin, the EBITDA margins sank by 38 bps yoy. The management had given a rich guidance of 40% yoy growth for FY08 and have maintained there position of stable to better margins.

The current order book stands at Rs. 36.72bln (0up by 66%yoy) that is 1.42x net sales of FY07 offering visibility for future growth.

Sharekhan Research maintained purchase rating on Sun Pharmaceutical Industries with target price of Rs 1287. At current market price Rs 965, stock valued at 21.6x FY2008E and 18.1xFY2009E fully diluted earnings.

Result highlights:

Emkay Research report on GTL:

According to technical Analyst, Sudarshan Sukhani the investors should stay away from

Finquest Research is expecting Kewal Kiran Clothing and rec

The BSE Sensex was in a pessimistic mode today and finished the day with a nearly 100 points deficit.

Remarking on the weak spot in the market technical analyst Vishwas Agarwal believed that the weakness was mainly because of factors upsetting the international markets, which were also down today.

He added that a few spheres that had caught rather a sharp increase in the past few days including cement and banking were calming down slightly. Simultaneously some increase is envisioned in fence sitters like ITC, Reliance Capital and Infosys.